NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Tag: JAMA

7/21/2020

JAMA: Communicating Science in the Time of a Pandemic

2 11/27/2018

Is social media hurting science … and people?

7/11/2018

Screening for atrial fibrillation with a wearable patch: Seek and ye shall find … and then what?

1 6/14/2018

Headlines raise alarm over prescription drug depression risk. But who qualifies as depressed?

1 4/19/2018

Between news release hype and peer-reviewed publication, patients wait in limbo

4 3/8/2018

Prostate cancer screening: massive study gets minimal coverage. Why?

6 4/17/2017

Selling Adult ADHD: NPR coverage helps advance drug industry marketing campaign

1/19/2017

Is it asthma? Many diagnosed with condition receive unnecessary or incorrect treatment

8/31/2016

A new osteoporosis drug that’s “better” than an existing option? How this misleading message reached consumers and how it could have been avoided

1 6/10/2015

A flawed news release, and the resulting coverage, of a study on breastfeeding and leukemia